1. ALLA AKTIER
  2. NYHETER
  3. ZICCUM

Ziccum

Nyheter Ziccum Nyheter alla bolag

Ziccum to attend BIO-Europe Spring in Basel

Ziccum CEO Ann Gidner and Chairman Fredrik Sjövall will attend the BIO-Europe Spring 2023 Conference in Basel, Switzerland March 20 – 22. The event attracts pharma and biopharma corporations from across the globe. The latest updates from Ziccum technology development will be presented at meetings at the event.

On March 20 – 22, Ziccum CEO Ann Gidner and Chairman Fredrik Sjövall will be onsite in Basel, Switzerland at one of the world’s leading pharma and biotech events - BIO-Europe Spring 2023.

The latest updates from Ziccum projects and technology development will be presented at partnering meetings, promoting the company’s unique LaminarPace drying technology for vaccines and biologics.

CEO Ann Gidner: “we look forward to attending BIO-Europe and sharing our latest findings and results with both existing partners and new contacts. It will certainly be a dynamic and productive event.”

For more information about Ziccum, please contact:

Ann Gidner,
CEO Ziccum
Mail: gidner@ziccum.com
Mobile: +46 722140141

Fredrik Sjövall,
Chairman of the Board, Ziccum AB
Mail: sjovall@ziccum.com
Mobile: +46 706 45 08 75
 
Ziccum’s Certified Adviser is Erik Penser Bank AB

About Ziccum

Ziccum is developing LaminarPaceTM, a unique ambient drying method for biopharmaceuticals and vaccines based on mass transfer, not heat transfer. The technology is offered by licensing to vaccine and biologics developers and manufacturers in the global pharmaceutical industry. By reducing drying stress to the active ingredient, LaminarPaceTM uniquely enables particle-engineered, thermostable dry powder biopharmaceuticals which can be easily handled and transported and are highly suitable for novel administration routes. The technology has been successfully applied to mRNA, peptides, proteins, antibodies, lipids and enzymes as well as excipients and adjuvants, and is well suited for industrial application. Ziccum is listed on the Nasdaq First North Growth Market.

Attachments

Ziccum to attend BIO-Europe Spring in Basel

Datum 2023-03-17, kl 08:40
Källa MFN
Bifogade filer
Ziccum to attend BIO-Europe Spring in Basel
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 125 000 sidvisningar och 17 000 unika besökare per månad. Vår discord har 7800 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!